Levepsy 500mg Injection
Marketer
Cipla Ltd
Salt Composition
Levetiracetam (500mg)
Overview Levepsy 500mg Injection
Epileptic seizures are managed with the anticonvulsant Levepsy 500mg Injection. Administered intravenously as a slow infusion by a medical professional, it offers short-term seizure control when oral medication is impractical, such as in unconscious patients. This injectable treatment is effective only while actively administered and should be continued as directed, even if symptoms improve; discontinuation or missed doses may exacerbate seizures. Long-term seizure management typically transitions to oral medication following the injection course. Common side effects, often subsiding after initial use, include headache, drowsiness, nausea, infection, throat irritation, and behavioral alterations (aggressiveness, irritability). Serious side effects, such as allergic reactions (rash, hives, breathing difficulties, facial swelling), require immediate medical attention. Suicidal thoughts have been reported in a small percentage of patients; report any mood deterioration to your doctor immediately. Prior to treatment, inform your doctor of any kidney issues, pre-existing depression, suicidal ideation, or pregnancy. Alcohol consumption should be avoided due to increased seizure risk and intensified side effects. Drowsiness may impair driving or operating machinery. Regular kidney function monitoring may be necessary.
Uses of Levepsy 500mg Injection
Managing Epileptic Seizures
Major Benefits of Levepsy 500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Levepsy 500mg Injection:
- Sleepiness
- Dizziness
- Decreased appetite
- Fatigue
- Headache
- Behavioral changes
- Irritation
- Aggressive behavior
- Agitation
- Infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Levepsy 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Levepsy 500mg Injection works:
Levepsy 500mg injection, an anticonvulsant, targets synaptic vesicle protein 2A (SV2A) receptors on neuronal membranes. This binding action inhibits excessive neuronal firing in the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Levepsy 500mg Injection poses a significant safety risk.
PregnancyCONSULT YOUR DOCTOR
Administering Levepsy 500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Levepsy 500mg Injection during lactation is likely safe. Available human data indicate minimal risk to the infant. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Administering Levepsy 500mg Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with kidney impairment, administration of Levepsy 500mg Injection requires careful monitoring. Dosage modification of Levepsy 500mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Levepsy 500mg Injection is likely safe for individuals with liver impairment. Existing evidence indicates dose modification of Levepsy 500mg Injection may be unnecessary in such cases. Physician consultation is recommended. Nevertheless, a reduced dosage might be preferable for patients exhibiting severe hepatic dysfunction.
What if you forget to take Levepsy 500mg Injection :
Should you forget a Levepsy 500mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed injection and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Levepsy 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinone-Acetamide Compound |
| Developing Habits | No. |
| Type of Therapy | Central Nervous System (CNS) Neurology |
| Action Class | AED: A protein ligand bound to synaptic vesicle 2 |

